Adamis Pharmaceuticals Corp
Company Snapshot: Adamis Pharmaceuticals Corp
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology. In its specialty pharmaceutical pipeline, ADMP is developing low cost therapeutic alternatives for the treatment of anaphylaxis, asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. Within the Company's biotechnology pipeline is a novel cell-based therapeutic cancer vaccine and three drug candidates for the treatment of prostate cancer.
- Sep 18 2020 Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
- Sep 17 2020 Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
- Sep 3 2020 Adamis Pharmaceuticals Provides Update on Annual Meeting of Stockholders
- Aug 25 2020 Adamis Pharmaceuticals Provides Update on Annual Meeting of Stockholders and Proposals